HK-listed gold stocks jump as US economic fears boost bullion prices
Investing.com - IRIDEX reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
IRIDEX announced earnings per share of $-0.110 on revenue of $14.64M. Analysts polled by Investing.com EPS of $-0.130 on revenue of $14.49M.
IRIDEX 's are down 28.35% and is trading at $2.300 , still down 78.00% from its 52 week high of $9.18 set on Thursday, November 11, 2021.
IRIDEX shares gained 13.86% to trade at $2.300 in after-hours trade the report.
IRIDEX follows other major Healthcare sector earnings this month
IRIDEX's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar